0001209191-15-039680.txt : 20150506
0001209191-15-039680.hdr.sgml : 20150506
20150506211209
ACCESSION NUMBER: 0001209191-15-039680
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150504
FILED AS OF DATE: 20150506
DATE AS OF CHANGE: 20150506
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tibira Therapeutics, Inc.
CENTRAL INDEX KEY: 0001311596
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030422069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 GATEWAY BLVD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-6625
MAIL ADDRESS:
STREET 1: 701 GATEWAY BLVD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Regado Biosciences Inc
DATE OF NAME CHANGE: 20041215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frazier Healthcare V, LP
CENTRAL INDEX KEY: 0001341169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35953
FILM NUMBER: 15839103
BUSINESS ADDRESS:
STREET 1: 601 UNION STREET, SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: (206) 621-7200
MAIL ADDRESS:
STREET 1: 601 UNION STREET, SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-04
0
0001311596
Tibira Therapeutics, Inc.
TBRA
0001341169
Frazier Healthcare V, LP
FRAZIER HEALTHCARE
70 WILLOW ROAD, SUITE 200
MENLO PARK
CA
94025
0
0
1
0
Common Stock
2015-05-04
4
A
0
2668570
0.00
A
2668570
D
Reporting Person received 2,513,203 of such shares in exchange for shares of Tobira Therapeutics, Inc. ("Tobira") common stock in connection with the merger of Tobira into Issuer (the "Merger"). Pursuant to the terms of the Merger agreement each share of Tobira common stock will automatically be converted into the right to receive 1.43 shares of Issuer common stock. Reporting Person purchased 155,367 of such shares from Issuer pursuant to a Purchase Agreement.
/s/ Christopher Reilly, attorney-in-fact
2015-05-06